FAU AND SANCILIO & COMPANY, INC. JOIN FORCES TO TRAIN DRUG DEVELOPMENT WORKFORCE

sciOn the heels of its 20- year anniversary, Florida Atlantic University’s Center for Molecular Biology and Biotechnology (CMBB) on the John D. MacArthur Campus in Jupiter, continues to fulfill its mission in building a true biotechnology hub in the region. The Center has established the University’s first-of-its-kind university/industry partnership to train highly skilled workers in biopharmaceuticals and drug development.

Scientists from Riviera Beach based Sancilio & Company, Inc., a local biotech company founded in 2005, have begun teaching a graduate level course on FAU’s Jupiter campus titled, “Drug Development and Regulation,” to help meet their unique workforce needs. With 28 current job openings, the company typically has to search outside the state to fill these positions. Students who participate in the course attend lectures by Sancilio & Company scientists and also receive hands-on laboratory experience learning how to prepare and analyze pharmaceutical solutions. The course also provides them with industry knowledge and background on FDA regulations.

MORE “FAU AND SANCILIO & COMPANY, INC. JOIN FORCES TO TRAIN DRUG DEVELOPMENT WORKFORCE”

Electron Microscopy Core from Max Planck Florida Institute for Neuroscience Will Host a 2 Day Workshop

image003

Would you like to learn more about correlative light- and electron- microscopy (CLEM)?

The Electron Microscopy Core from Max Planck Florida Institute for Neuroscience will host this exciting 2-day workshop, providing you with educational lectures by experts in the field and hands-on training that you can adapt to your own projects. Attendees will explore the basics of CLEM applications, and learn practical workflows for how to correlate functional fluorescence imaging to high-resolution EM imaging in the hands-on demonstration using our state-of-the-art equipment.

MORE “Electron Microscopy Core from Max Planck Florida Institute for Neuroscience Will Host a 2 Day Workshop”

Transdermal Delivery Solutions & ALZYN Announce License for HypoSpray® Delivery of Alzheimers Therapy

transdermalTransdermal Delivery Solutions, a leader in the development of spray-on drug delivery systems, and ALZYN, LLC, an early stage company focused on addressing Alzheimer’s Disease, announced that they have signed a license agreement for development of a HypoSpray-delivered proprietary solution targeted at halting the progression of AD.

MORE “Transdermal Delivery Solutions & ALZYN Announce License for HypoSpray® Delivery of Alzheimers Therapy”

Jupiter Orphan Therapeutics, Inc. strengthens its Advisory Boards

jotJupiter Orphan Therapeutics, Inc. (JOT) today announced that Professor Li-Huei Tsai, Ph.D. and Professor Scott Turner, Ph.D. joined the JOT Scientific Advisory Board, and Robert Hahl, Ph.D. have joined the JOT Business Advisor Board. “It is a true honor to have these world renowned scientists joining JOT. This is also a
statement and verification to the science and pipeline we have developed in a very short period of time.” stated JOT CEO, Christer Rosén.

MORE “Jupiter Orphan Therapeutics, Inc. strengthens its Advisory Boards”

BOCA RATON REGIONAL HOSPITAL FIRST IN SOUTH FLORIDA TO OFFER NEW INNOVATION IN ENDOSCOPIC BIOPSIES

br hos2222222222Boca Raton Regional Hospital’s Stephen Steinberg, MD, is now performing biopsies on at-risk patients during standard endoscopy procedures to view internal tissues at the microscopic level instantaneously. Boca Regional was the first in South Florida and is the only hospital in Palm Beach County to offer Cellvizio® to patients, which revolutionizes the diagnosis and treatment of certain cancers.

Cellvizio, the smallest, flexible microscope in the world, is an optical biopsy technology that enables tissue within the human body to be viewed directly at the cellular level. It allows for the detection of anomalies that are invisible to the naked eye in various different organs, particularly in the gastrointestinal, urinary and pulmonary systems.

MORE “BOCA RATON REGIONAL HOSPITAL FIRST IN SOUTH FLORIDA TO OFFER NEW INNOVATION IN ENDOSCOPIC BIOPSIES”

SANCILIO & COMPANY, INC. PRESENTS AT THE 12th INTERNATIONAL SOCIETY FOR THE STUDY OF FATTY ACIDS AND LIPIDS (ISSFAL) CONGRESS

scilogo_vectorshiny-4Sancilio & Company, Inc. (SCI) announced the participation of members of the leadership team at the 12th ISSFAL Congress in Stellenbosch, South Africa where several scientific presentations from the company’s current research will be delivered.

The presentations will update the research community on the preclinical and clinical work being performed to support Sancilio’s late stage development programs in critical medical conditions such as Short Bowel Syndrome (SBS), Severe Hypertriglyceridemia, and Sickle Cell Disease (SCD).

MORE “SANCILIO & COMPANY, INC. PRESENTS AT THE 12th INTERNATIONAL SOCIETY FOR THE STUDY OF FATTY ACIDS AND LIPIDS (ISSFAL) CONGRESS”